A preliminary operational classification system for nonmutagenic modes of action for carcinogenesis.
This article proposes a system of categories for nonmutagenic modes of action for carcinogenesis. The classification is of modes of action rather than individual carcinogens, because the same compound can affect carcinogenesis in more than one way. Basically, we categorize modes of action as: (1) co-initiation (facilitating the original mutagenic changes in stem and progenitor cells that start the cancer process) (e.g. induction of activating enzymes for other carcinogens); (2) promotion (enhancing the relative growth vs differentiation/death of initiated clones (e.g. inhibition of growth-suppressing cell-cell communication); (3) progression (enhancing the growth, malignancy, or spread of already developed tumors) (e.g. suppression of immune surveillance, hormonally mediated growth stimulation for tumors with appropriate receptors by estrogens); and (4) multiphase (e.g., "epigenetic" silencing of tumor suppressor genes). A priori, agents that act at relatively early stages in the process are expected to manifest greater relative susceptibility in early life, whereas agents that act via later stage modes will tend to show greater susceptibility for exposures later in life.
Hattis
D
D
George Perkins Marsh Institute, Clark University, Worcester, Massachusetts, USA.
Chu
M
M
Rahmioglu
N
N
Goble
R
R
Verma
P
P
Hartman
K
K
Kozlak
M
M
D000818:Animals; D015197:Carcinogenicity Tests; D002273:Carcinogens / Q000145:classification* / Q000633:toxicity; D018450:Disease Progression; D020868:Gene Silencing; D016147:Genes, Tumor Suppressor / Q000187:drug effects; D006801:Humans; D009153:Mutagens / Q000633:toxicity; D009369:Neoplasms / Q000139:chemically induced*; D013997:Time Factors
D002273:Carcinogens; D009153:Mutagens